Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CIMA Technology is a privately held U.S. ophthalmic medical device company operating under the brand CIMA Life Science. The company designs, manufactures, and distributes intraocular lenses, ophthalmic viscosurgical devices, staining and related ophthalmic solutions, and injector systems used primarily in cataract surgery. Its product portfolio includes the CIMflex and Asteri intraocular lens families and OVD brands such as OcuMax, Ocu+, BiVisc, Visc II, and CIMgel. CIMA emphasizes U.S.-made products, export-oriented distribution, and partnerships with ophthalmologists and NGOs serving international markets. The business appears to be a commercial-stage device manufacturer rather than a therapeutics developer, with activity centered on surgical ophthalmology products rather than a drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CIMA Technology.